BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7888204)

  • 1. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
    Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
    Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augment binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independency of G-tetrad formation.
    Lederman S; Sullivan G; Benimetskaya L; Lowy I; Land K; Khaled Z; Cleary AM; Yakubov L; Stein CA
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):281-9. PubMed ID: 9012864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a phosphodiester hexanucleotide that inhibits HIV-1 infection in vitro on covalent linkage of its 5'-end with a dimethoxytrityl residue.
    Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):167-75. PubMed ID: 9212907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene.
    Halliday SM; Lackman-Smith C; Bader JP; Rice WG; Clanton DJ; Zalkow LH; Buckheit RW
    Antiviral Res; 1996 Dec; 33(1):41-53. PubMed ID: 8955852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of G-quartet-mediated tetramer formation.
    Wyatt JR; Davis PW; Freier SM
    Biochemistry; 1996 Jun; 35(24):8002-8. PubMed ID: 8672504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual single-stranded polyribonucleotides as potent anti-HIV agents.
    Broom AD; Agrawal VK; Tutonda MG; Fain HD; Buckheit RW
    J Med Chem; 1995 Aug; 38(17):3253-7. PubMed ID: 7650678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.
    Stein CA; Neckers LM; Nair BC; Mumbauer S; Hoke G; Pal R
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):686-93. PubMed ID: 1711118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320.
    Stoddart CA; Rabin L; Hincenbergs M; Moreno M; Linquist-Stepps V; Leeds JM; Truong LA; Wyatt JR; Ecker DJ; McCune JM
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2113-5. PubMed ID: 9687417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T; Sakata T; Kaji A; Kaji H
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorothioate hammerhead ribozymes targeting a conserved sequence in the V3 loop region inhibit HIV-1 entry.
    Zhang X; Iwatani Y; Shimayama T; Yamada R; Koito A; Xu Y; Sakai H; Uchiyama T; Hattori T
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):441-50. PubMed ID: 9918108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins.
    Hansen JE; Nielsen CM; Nielsen C; Heegaard P; Mathiesen LR; Nielsen JO
    AIDS; 1989 Oct; 3(10):635-41. PubMed ID: 2574581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death.
    Callebaut C; Jacotot E; Guichard G; Krust B; Rey-Cuille M; Cointe D; Benkirane N; Blanco J; Muller S; Briand J; Hovanessian AG
    Virology; 1996 Apr; 218(1):181-92. PubMed ID: 8615021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide.
    Bishop JS; Guy-Caffey JK; Ojwang JO; Smith SR; Hogan ME; Cossum PA; Rando RF; Chaudhary N
    J Biol Chem; 1996 Mar; 271(10):5698-703. PubMed ID: 8621435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
    Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
    Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
    Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
    Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.
    Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro.
    Swart PJ; Kuipers ME; Smit C; Pauwels R; deBéthune MP; de Clercq E; Meijer DK; Huisman JG
    AIDS Res Hum Retroviruses; 1996 Jun; 12(9):769-75. PubMed ID: 8738428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.